AstraZeneca PLC – Key Topics Discussed by Investors

By Blake Campbell • Friday, July 04 10:06 • Permanent Link

AstraZeneca PLC logged a -2.4% change during today's morning session, and is now trading at a price of $69.45 per share. The S&P 500 index moved 1.0%. AZN's trading volume is 6,768,010 compared to the stock's average volume of 5,228,727.

If you are considering an investment in AZN, you'll want to know the following:

AstraZeneca PLC's current price is 35.0% above its Graham number of $51.45, which implies that at its current valuation it does not offer a margin of safety
AstraZeneca PLC has moved -10.2% over the last year, and the S&P 500 logged a change of 12.8%
Based on its trailing earnings per share of 2.49, AstraZeneca PLC has a trailing 12 month Price to Earnings (P/E) ratio of 27.9 while the S&P 500 average is 29.3
AZN has a forward P/E ratio of 12.7 based on its forward 12 month price to earnings (EPS) of $5.49 per share
Its Price to Book (P/B) ratio is 2.62 compared to its sector average of 3.19
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
Based in Cambridge, the company has 94,300 full time employees and a market cap of $221.39 Billion. AstraZeneca PLC currently returns an annual dividend yield of 4.4%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.